Publicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (7)

2023

  1. What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study

    Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3479-3491

2018

  1. Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

    Oncologist, Vol. 23, Núm. 11, pp. 1271-e128

2017

  1. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

  2. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

    European Journal of Cancer, Vol. 82, pp. 16-24

2015

  1. Clinical guideline SEOM: hepatocellular carcinoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995

2011

  1. Evaluación ecónomica de capecitabina + cisplatino frente a 5-FU + cisplatino en el tratamiento en primera línea de cáncer gástrico avanzado en España

    Pharmacoeconomics - Spanish Research Articles, Vol. 8, Núm. 2, pp. 51-58

  2. Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain

    Clinical and Translational Oncology, Vol. 13, Núm. 12, pp. 862-868